Definium Therapeutics (DFTX) Cash & Equivalents Growth (3y) (2023 - 2026)
Definium Therapeutics (DFTX) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
24.73% |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
- |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
- |
| 10 |
Definium Therapeutics |
2.42 Bn |
2.05 Bn |
- |
25.73% |
| Date | Value |
|---|
| Mar 31, 2026 |
25.73% |
| Dec 31, 2025 |
24.69% |
| Sep 30, 2025 |
-47.83% |
| Jun 30, 2025 |
-31.90% |
| Dec 31, 2023 |
7.57% |
